Yes the potential is there , it has been there for 40 years when they first started the research. The longs hear have heard all the things they have been working on with no published results that was to be coming.
Now we can look at the following questions and welcome feedback with facts
1) 100B dollar value of the next 10 years , haven seen that start yet and that was thru 2030 prediction by ENZC
2) Multiple claims of test with results due in 6 months , over two years now. You want to see them I posted them before
3) A cure that hasn't been approved or even a completed trial to prove what they stated in multiple PR's, saying good results were reported when the trial wasn't completed doesn't prove it works, that is the only statement they have said about the cure. Never said we have cured a single animal or person, so it isn't a cure. If they had cured anything they would have been bought out or funded by a partner long ago and we wouldn't be talking about a OTC company tied up with a disfunction SPAC
4) Africa trials that were talked about in 2021 and were upcoming , then we saw it all blowup this past year.
5) No funding to support the above statements , if they did then the SPAC would not be needed. If they had results and money they would have been up listing or a better deal on the table by BP. The NASDAQ dream is great but the wrong SPAC was picked due to the mishandled filings, multiple violations and lack of securing funding. Throw in the shady BS SAGA and ENZC went along with, no way they didn't know what was going on the lack of filings were easy to lookup by CC. Yes the funding is not secured that is why they need more time to find groups that will over look a SPAC that can't manage or close a deal on time. An OTC company that hasn't met a goal they have set, especially when they stated up listing, audited financials were top on list for 2 years , partnerships other than the Bulgarian backers which was to be paying for testing in EU which we have heard nothing about over the past two years. So it might be hard to get 450M backing when they look into the history of both SAGA and how ENZC has handled themselves both as a company and their management team social media blunders, along with failures to meet their own PR statements.
This isn't bashing this is pointing out the facts that they have told us in PR's , failed deadlines and is why the SP is where it is until the next PR that gives hope, which many including me are hoping for another .10 or better I see many of us selling off. For the ones that say don't marry a penny stock many were not they were going by what the company itself was stating and was assuming the up listing was going to happen based off CC , test results would start coming in and a buyout , major funding or a partnership was going to happen to increase the value of the ENZOLYTICS Brand. Instead we are waiting on court rulings on a fly by night SPAC run by a shady Barry K that had to settle lawsuits and pay people off to keep from going to jail. So what seems to us looking at all the facts it appears that Enzolytics management team was looking at how they could separate two companies out of Enzolytics have control of them and have 20M in their names alone. So until we hear the ruling , we hear from Enzolytics themselves with a honest statement and not a fluff piece they have no creditability to me, based off the last 3 years of BS and no follow thru that has resulted in value added to Enzolytics the company that many of us put money in.
Happy Holidays everyone , be safe and enjoy your family and friends.
News 
Market Data 
Discover 
AI
